skip to content
Primary navigation


Drug - Omeclamox-Pac [Pernix Therapeutics]

June 2014

Therapeutic area - H. Pylori

Approval criteria

Patient has tried and failed PrevPac.

Background information

Omeclamox-Pac is indicated for the treatment of H. pylori infection and duodenal ulcer disease. The regimen has the same active ingredients, in the same strengths as PrePac, with the exception of the proton pump inhibitor components, but is significantly more costly.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top